It was a pleasure to spend time with the Peter MacCallum Cancer Centre team in Australia as they showed us around their cutting-edge facilities.

As a collaborator, CellVec manufactures and supplies lentiviral vectors for Australia’s Peter MacCallum Cancer Center’s in-house pipeline of cell-based immunotherapies.